HirsutineCAS# 7729-23-9 |
- Dihydrocorynantheine
Catalog No.:BCN3747
CAS No.:4684-43-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 7729-23-9 | SDF | Download SDF |
PubChem ID | 3037884 | Appearance | Powder |
Formula | C22H28N2O3 | M.Wt | 368.47 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | methyl (E)-2-[(2S,3R,12bR)-3-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate | ||
SMILES | CCC1CN2CCC3=C(C2CC1C(=COC)C(=O)OC)NC4=CC=CC=C34 | ||
Standard InChIKey | NMLUOJBSAYAYEM-AZQGJTAVSA-N | ||
Standard InChI | InChI=1S/C22H28N2O3/c1-4-14-12-24-10-9-16-15-7-5-6-8-19(15)23-21(16)20(24)11-17(14)18(13-26-2)22(25)27-3/h5-8,13-14,17,20,23H,4,9-12H2,1-3H3/b18-13+/t14-,17-,20+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Hirsutine has anticancer, cardioprotective, anti‑hypertensive and anti-arrhythmic activities, it also has vasodilatation activity, the mechanism is related to blockade of Ca2+ influx through L-type Ca2+ channels and inhibition of intracellular Ca2+ release may have no relationship with K+ channels. Hirsutine reduces the production of various neurotoxic factors in activated microglial cells and possesses neuroprotective activity in a model of inflammation-induced neurotoxicity. |
Targets | p53 | NF-kB | Akt | p38MAPK | MMP(e.g.TIMP) | Calcium Channel | Potassium Channel | NO | PGE | IL Receptor |
In vitro | Selective anticancer activity of hirsutine against HER2‑positive breast cancer cells by inducing DNA damage.[Pubmed: 25672479]Oncol Rep. 2015 Apr;33(4):2072-6.Hirsutine is one of the major alkaloids isolated from plants of the Uncaria genus and is known for its cardioprotective, anti‑hypertensive and anti-arrhythmic activities.
We recently reported that Hirsutine is an anti-metastatic phytochemical by targeting NF-κB activation in a murine breast cancer model.
Effects of hirsutine, an antihypertensive indole alkaloid from Uncaria rhynchophylla, on intracellular calcium in rat thoracic aorta.[Pubmed: 1311793]Life Sci. 1992;50(7):491-8.The effects of Hirsutine, an indole alkaloid from Uncaria rhynchophylla (MIQ.) Jackson, on cytosolic Ca2+ level ([Ca2+]cyt) were studied by using fura-2-Ca2+ fluorescence in smooth muscle of the isolated rat aorta.
|
In vivo | Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits inflammation-mediated neurotoxicity and microglial activation.[Pubmed: 23117160]Mol Med Rep. 2013 Jan;7(1):154-8.Chronic microglial activation endangers neuronal survival through the release of various pro-inflammatory and neurotoxic factors. As such, negative regulators of microglial activation have been considered as potential therapeutic candidates to reduce the risk of neurodegeneration associated with inflammation. Uncaria rhynchophylla (U. rhynchophylla) is a traditional oriental herb that has been used for treatment of disorders of the cardiovascular and central nervous systems. Hirsutine (HS), one of the major indole alkaloids of U. rhynchophylla, has demonstrated neuroprotective potential.
|
Kinase Assay | The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.[Pubmed: 25909998]Identification of Hirsutine as an anti-metastatic phytochemical by targeting NF-κB activation.[Pubmed: 25175557 ]Int J Oncol. 2014 Nov;45(5):2085-91.Nuclear factor-κB (NF-κB) activation has been implicated not only in carcinogenesis but also in cancer cell invasion and metastatic process; therefore, targeting the NF-κB pathway is an attractive strategy for controlling meta-stasis.
PLoS One. 2015 Apr 24;10(4):e0119477.
|
Hirsutine Dilution Calculator
Hirsutine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7139 mL | 13.5696 mL | 27.1393 mL | 54.2785 mL | 67.8481 mL |
5 mM | 0.5428 mL | 2.7139 mL | 5.4279 mL | 10.8557 mL | 13.5696 mL |
10 mM | 0.2714 mL | 1.357 mL | 2.7139 mL | 5.4279 mL | 6.7848 mL |
50 mM | 0.0543 mL | 0.2714 mL | 0.5428 mL | 1.0856 mL | 1.357 mL |
100 mM | 0.0271 mL | 0.1357 mL | 0.2714 mL | 0.5428 mL | 0.6785 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Edelfosine
Catalog No.:BCC7537
CAS No.:77286-66-9
- Fmoc-Nle-OH.
Catalog No.:BCC3298
CAS No.:77284-32-3
- Zederone
Catalog No.:BCN3524
CAS No.:7727-79-9
- Abyssinone V
Catalog No.:BCN6825
CAS No.:77263-11-7
- Erythrabyssin II
Catalog No.:BCN4828
CAS No.:77263-06-0
- MG 624
Catalog No.:BCC7028
CAS No.:77257-42-2
- Carboxyatractyloside
Catalog No.:BCN2880
CAS No.:77228-71-8
- Nefiracetam
Catalog No.:BCC4504
CAS No.:77191-36-7
- Rheediaxanthone A
Catalog No.:BCN7411
CAS No.:77181-97-6
- Acetylaconitine
Catalog No.:BCN2407
CAS No.:77181-26-1
- Delta-Caesalpin
Catalog No.:BCN6698
CAS No.:7716-14-5
- Spiraline
Catalog No.:BCN2112
CAS No.:77156-25-3
- SL 0101-1
Catalog No.:BCC8086
CAS No.:77307-50-7
- Hyuganin D
Catalog No.:BCN7679
CAS No.:77331-76-1
- Acamprosate calcium
Catalog No.:BCC1327
CAS No.:77337-73-6
- Triacetylpseurotin A
Catalog No.:BCN6916
CAS No.:77353-57-2
- Drimiopsin C
Catalog No.:BCN4325
CAS No.:773850-90-1
- Drimiopsin D
Catalog No.:BCN4326
CAS No.:773850-91-2
- Sesartemin
Catalog No.:BCN4779
CAS No.:77394-27-5
- Episesartemin A
Catalog No.:BCN7239
CAS No.:77449-31-1
- 5-Androsten-3β-ol-17-one ethyleneketal
Catalog No.:BCC8738
CAS No.:7745-40-6
- KM 11060
Catalog No.:BCC7578
CAS No.:774549-97-2
- Pimobendan hydrochloride
Catalog No.:BCC4175
CAS No.:77469-98-8
- Phenylpiracetam
Catalog No.:BCC1859
CAS No.:77472-70-9
Selective anticancer activity of hirsutine against HER2positive breast cancer cells by inducing DNA damage.[Pubmed:25672479]
Oncol Rep. 2015 Apr;33(4):2072-6.
Hirsutine is one of the major alkaloids isolated from plants of the Uncaria genus and is known for its cardioprotective, antihypertensive and anti-arrhythmic activities. We recently reported that Hirsutine is an anti-metastatic phytochemical by targeting NF-kappaB activation in a murine breast cancer model. In the present study, we further examined the clinical utility of Hirsutine against human breast cancer. Among six distinct human breast cancer cell lines, Hirsutine showed strong cytotoxicity against HER2-positive/p53-mutated MDA-MB453 and BT474 cell lines. Conversely, HER2-negative/p53 wildtype MCF-7 and ZR-75-1 cell lines showed resistance against Hirsutine-induced cytotoxicity. Hirsutine induced apoptotic cell death in the MDA-MB-453 cells, but not in the MCF-7 cells, through activation of caspases. Furthermore, Hirsutine induced the DNA damage response in the MDA-MB-453 cells, but not in the MCF-7 cells, as highlighted by the upregulation of gammaH2AX expression. Along with the induction of the DNA damage response, the suppression of HER2, NF-kappaB and Akt pathways and the activation of the p38 MAPK pathway in the MDA-MB-453 cells were observed. Considering that there was no difference between MDA-MB-453 and MCF-7 cells in regards to irinotecaninduced DNA damage response, our present results indicate the selective anticancer activity of Hirsutine in HER2-positive breast cancer by inducing a DNA damage response.
Effects of hirsutine, an antihypertensive indole alkaloid from Uncaria rhynchophylla, on intracellular calcium in rat thoracic aorta.[Pubmed:1311793]
Life Sci. 1992;50(7):491-8.
The effects of Hirsutine, an indole alkaloid from Uncaria rhynchophylla (MIQ.) Jackson, on cytosolic Ca2+ level ([Ca2+]cyt) were studied by using fura-2-Ca2+ fluorescence in smooth muscle of the isolated rat aorta. Noradrenaline and high K+ solution produced a sustained increase in [Ca2+]cyt. Application of Hirsutine after the increases in [Ca2+]cyt induced by noradrenaline and high K+ notably decreased [Ca2+]cyt, suggesting that Hirsutine inhibits Ca2+ influx mainly through a voltage-dependent Ca2+ channel. Furthermore, the effect of Hirsutine on intracellular Ca2+ store was studied by using contractile responses to caffeine under the Ca(2+)-free nutrient condition in the rat aorta. When Hirsutine was added at 30 microM before caffeine treatment, the agent slightly but significantly reduced the caffeine-induced contraction. When added during Ca2+ loading, Hirsutine definitely augmented the contractile response to caffeine. These results suggest that Hirsutine inhibits Ca2+ release from the Ca2+ store and increases Ca2+ uptake into the Ca2+ store, leading to a reduction of intracellular Ca2+ level. It is concluded that Hirsutine reduces intracellular Ca2+ level through its effect on the Ca2+ store as well as through its effect on the voltage-dependent Ca2+ channel.
Hirsutine, an indole alkaloid of Uncaria rhynchophylla, inhibits inflammation-mediated neurotoxicity and microglial activation.[Pubmed:23117160]
Mol Med Rep. 2013 Jan;7(1):154-8.
Chronic microglial activation endangers neuronal survival through the release of various pro-inflammatory and neurotoxic factors. As such, negative regulators of microglial activation have been considered as potential therapeutic candidates to reduce the risk of neurodegeneration associated with inflammation. Uncaria rhynchophylla (U. rhynchophylla) is a traditional oriental herb that has been used for treatment of disorders of the cardiovascular and central nervous systems. Hirsutine (HS), one of the major indole alkaloids of U. rhynchophylla, has demonstrated neuroprotective potential. The aim of the present study was to examine the efficacy of HS in the repression of inflammation-induced neurotoxicity and microglial cell activation. In organotypic hippocampal slice cultures, HS blocked lipopolysaccharide (LPS)-related hippocampal cell death and production of nitric oxide (NO), prostaglandin (PG) E2 and interleukin-1beta. HS was demonstrated to effectively inhibit LPS-induced NO release from cultured rat brain microglia. The compound reduced the LPS-stimulated production of PGE2 and intracellular reactive oxygen species. HS significantly decreased LPS-induced phosphorylation of the mitogen-activated protein kinases and Akt signaling proteins. In conclusion, HS reduces the production of various neurotoxic factors in activated microglial cells and possesses neuroprotective activity in a model of inflammation-induced neurotoxicity.
Identification of Hirsutine as an anti-metastatic phytochemical by targeting NF-kappaB activation.[Pubmed:25175557]
Int J Oncol. 2014 Nov;45(5):2085-91.
Nuclear factor-kappaB (NF-kappaB) activation has been implicated not only in carcinogenesis but also in cancer cell invasion and metastatic process; therefore, targeting the NF-kappaB pathway is an attractive strategy for controlling meta-stasis. Amongst 56 chemically defined compounds derived from natural products, we have identified a new phytochemical compound Hirsutine, which strongly suppresses NF-kappaB activity in murine 4T1 breast cancer cells. In accordance with the NF-kappaB inhibition, Hirsutine reduced the metastatic potential of 4T1 cells, as seen in the inhibition of the migration and invasion capacity of 4T1 cells. Hirsutine further inhibited the constitutive expression of MMP-2 and MMP-9 in 4T1 cells, and reduced the in vivo lung metastatic potential of 4T1 cells in the experimental model. Given that the migration of human breast cancer cells was also inhibited, our present study implies that Hirsutine is an attractive phytochemical compound for reducing metastasis potential of cancer cells by regulating tumor-promoting NF-kappaB activity.
The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.[Pubmed:25909998]
PLoS One. 2015 Apr 24;10(4):e0119477.
In this paper, an analogue of Hirsutine (compound 1) has been synthesized and evaluated as an anti-hypertension agent, which exhibits extraordinary effects on the contractile response of thoracic aorta rings from male SD rats in vitro (IC50 = 1.129x10(-9)+/-0.5025) and the abilities of reducing the systolic blood pressure (SBP) and heart rate (HR) of SHR in vivo. The mechanism investigation reveals that the vasodilatation induced by compound 1 is mediated by both endothelium-dependent and -independent manners. The relaxation in endothelium-intact aortic rings induced by compound 1 can be inhibited by L-NAME (1x10(-6) mol*L(-1)) and ODQ (1x10(-6) mol*L(-1)). Moreover, compound 1 can also block Ca2+ influx through L-type Ca2+ channels and inhibit intracellular Ca2+ release while no effect on K+ channel has been observed. All these data demonstrated that the NO/cyclic GMP pathway can be involved in endothelium-dependent manner induced by compound 1. Meanwhile the mechanism on the vasodilatation of compound 1 probably also related to blockade of Ca2+ influx through L-type Ca2+ channels and inhibition of intracellular Ca2+ release may have no relationship with K+ channels.